Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Aromatase Inhibitors × Breast × Clear all

Phase

Phase 2 42 Phase 3 20 Phase 1 6 Phase NA 3 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Capecitabine 17 Paclitaxel 16 Docetaxel 13 Cyclophosphamide 11 Carboplatin 11 Epirubicin 9 Trastuzumab 8 Letrozole 8 Gemcitabine 8 Doxorubicin 7 pertuzumab 5 Cisplatin 5 Vinorelbine 4 130-nm albumin-bound paclitaxel 4 exemestane 3 Zoledronic Acid 3 Tamoxifen 3 Neoadjuvant Therapy 3 Lapatinib 3 Drug Therapy 3 Ado-Trastuzumab Emtansine 3 AC protocol 3 pyrotinib 2 palbociclib 2 camrelizumab 2 apatinib 2 Thiotepa 2 Taxes 2 Standard of Care 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01654367 2012-07-31

esozao

Tianjin Medical University

Phase 2/3 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡